Product Code: ETC6188005 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The pertussis market in Australia centers around the prevention, diagnosis, and treatment of whooping cough, a contagious respiratory disease. Vaccination campaigns have significantly reduced the incidence of pertussis in Australia, but outbreaks still occur, particularly among infants and vulnerable populations. The market is driven by the demand for vaccines and antibiotics used in treating and preventing pertussis. Challenges include vaccine hesitancy, the emergence of new strains, and the ongoing need for public health campaigns to maintain high immunization rates. Additionally, improving access to treatment in rural and underserved areas is a critical concern.
The Australia Pertussis Market is shaped by the ongoing efforts to control and prevent whooping cough, especially among infants and vulnerable populations. Immunization campaigns and the introduction of booster shots are essential in reducing the incidence of pertussis. However, the rise of vaccine hesitancy is challenging public health strategies. Despite this, the market for pertussis vaccines continues to grow, as health authorities push for stronger vaccination programs and awareness campaigns. Additionally, advancements in vaccine formulations, including acellular vaccines, are contributing to the increased effectiveness and safety of pertussis immunization.
The Australia Pertussis Market faces challenges related to the increasing incidence of pertussis (whooping cough) in certain demographics, despite vaccination efforts. One of the primary challenges is maintaining high vaccination coverage across all age groups, particularly among pregnant women, infants, and vulnerable populations. The ongoing need for booster shots and the potential for vaccine hesitancy are additional hurdles. Furthermore, the rise of pertussis cases in adults, especially among those who have not received a booster shot, highlights gaps in immunization coverage. Additionally, there are concerns regarding the effectiveness of current vaccines, as some pertussis strains have shown resistance to existing vaccines.
The Pertussis Market in Australia presents investment opportunities in the development of advanced vaccines and treatments. With pertussis (whooping cough) continuing to be a concern, especially in infants and vulnerable populations, companies developing new vaccines or innovative therapies stand to benefit. Investment in vaccine production facilities and collaborations with governmental health agencies can be crucial for market success. Additionally, investing in educational campaigns to raise awareness of pertussis vaccination could also generate long-term returns, given the focus on public health.
In Australia, the government has implemented policies to combat pertussis (whooping cough), which is a vaccine-preventable disease. National immunization programs, such as the funded vaccination of infants and pregnant women, aim to reduce the incidence of pertussis. The government closely monitors pertussis outbreaks and enforces vaccination requirements to ensure high levels of immunity within the population. Policies also encourage research into new vaccines and treatments for pertussis, with funding allocated to support advancements in this field. Public health campaigns are regularly conducted to educate the population about the importance of vaccination.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pertussis Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pertussis Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pertussis Market - Industry Life Cycle |
3.4 Australia Pertussis Market - Porter's Five Forces |
3.5 Australia Pertussis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Australia Pertussis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Australia Pertussis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Pertussis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Australia Pertussis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Pertussis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Pertussis Market Trends |
6 Australia Pertussis Market, By Types |
6.1 Australia Pertussis Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Australia Pertussis Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Australia Pertussis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.1.4 Australia Pertussis Market Revenues & Volume, By Chest X-Ray, 2021- 2031F |
6.1.5 Australia Pertussis Market Revenues & Volume, By Nose or Throat Culture & Test, 2021- 2031F |
6.1.6 Australia Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Pertussis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Australia Pertussis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Australia Pertussis Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.2.4 Australia Pertussis Market Revenues & Volume, By Supportive Treatments, 2021- 2031F |
6.2.5 Australia Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Pertussis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Pertussis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Pertussis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Australia Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Pertussis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Pertussis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Pertussis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Australia Pertussis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Australia Pertussis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Pertussis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Pertussis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Australia Pertussis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Australia Pertussis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia Pertussis Market Import-Export Trade Statistics |
7.1 Australia Pertussis Market Export to Major Countries |
7.2 Australia Pertussis Market Imports from Major Countries |
8 Australia Pertussis Market Key Performance Indicators |
9 Australia Pertussis Market - Opportunity Assessment |
9.1 Australia Pertussis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Australia Pertussis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Australia Pertussis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Pertussis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Australia Pertussis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Pertussis Market - Competitive Landscape |
10.1 Australia Pertussis Market Revenue Share, By Companies, 2024 |
10.2 Australia Pertussis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |